Analyze Five Year Forecasts for the French Biotechnology Industry.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49025) has announced the addition of Biotechnology in France to their offering. Our Biotechnology in France industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies. Scope of this title: - Contains an executive summary and data on value, volume and segmentation - Provides textual analysis of the industry's prospects, competitive landscape and leading companies - Includes a five-year forecast of the industry - Supported by the key macroeconomic mac·ro·ec·o·nom·ics n. (used with a sing. verb) The study of the overall aspects and workings of a national economy, such as income, output, and the interrelationship among diverse economic sectors. and demographic data affecting the market Why you should buy this report - Spot future trends and developments - Inform your business decisions - Add weight to presentations and marketing materials - Save time carrying out entry-level research Market Definition The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding Research funding is a term generally covering any funding for scientific research, in the areas of both "hard" science and technology and social science. The term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and . Any currency conversions used in the creation of this report have been calculated using constant 2004 annual average exchange rates. For the purposes of this report, Europe consists of Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom, Bulgaria, Czech Republic Czech Republic, Czech Česká Republika (2005 est. pop. 10,241,000), republic, 29,677 sq mi (78,864 sq km), central Europe. It is bordered by Slovakia on the east, Austria on the south, Germany on the west, and Poland on the north. , Hungary, Poland, Romania, Russia, Slovakia and the Ukraine. Asia-Pacific consists of China, Hong Kong Hong Kong (hŏng kŏng), Mandarin Xianggang, special administrative region of China, formerly a British crown colony (2005 est. pop. 6,899,000), land area 422 sq mi (1,092 sq km), adjacent to Guangdong prov. , India, Japan, Malaysia, Singapore, South Korea, Vietnam, Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. . The global market is composed of Europe, Asia-Pacific, US, Canada, Turkey, Argentina, Brazil, Chile, Colombia, Mexico, Algeria, Egypt, Israel, UAE (Uninterruptible Application Error) The name given to a crash in Windows 3.0. In subsequent versions of Windows, a crash was called a "General Protection Fault," "Application Error" or "Illegal Operation." See crash in Windows and abend. , Saudi Arabia Saudi Arabia (sä  `dē ərā`bēə, sou`–, sô–), officially Kingdom of Saudi Arabia, kingdom (2005 est. pop. and South Africa. Topics Covered EXECUTIVE SUMMARY Chapter 1 Market overview 1.1 Market Definition 1.2 Research Highlights 1.3 Market Analysis Chapter 2 Market value Chapter 3 Market segmentation Market Segmentation A marketing term referring to the aggregating of prospective buyers into groups (segments) that have common needs and will respond similarly to a marketing action. i Chapter 4 Market segmentation ii Chapter 5 Competitive landscape Chapter 6 Leading companies 6.1 Biovector Therapeutics S.A. 6.2 Cerep 6.3 GenOdyssee 6.4 Transgene transgene a gene that has been incorporated into the genome of another organism. Chapter 7 Market forecasts 7.1 Market Value Forecast Chapter 8 Macroeconomic indicators Chapter 9 Further reading 9.1 Sources 9.2 Related Research List of Tables Table 1: France Biotechnology Market Value: $ billion, 2000-2004 Table 2: France Biotechnology Market Segmentation I: % Share, by Value, 2004 Table 3: France Biotechnology Market Segmentation II: % Share, by Value, 2004 Table 4: France Biotechnology Market Value Forecast: $ billion, 2004-2009 15 Table 5: France Size of Population (million) , 2000-2004 Table 6: France GDP GDP (guanosine diphosphate): see guanine. (1995=100), 2000-2004 Table 7: France Inflation, 2000-2004 Table 8: France Exchange Rate, 2000 Companies Mentioned - Biovector Therapeutics S.A. - Cerep - GenOdyssee - Transgene For more information visit http://www.researchandmarkets.com/reports/c49025 Source: Datamonitor |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion